PrEP attitudes, willingness, and preferences among men incarcerated in jail in Massachusetts
Name
12889_2025_Article_25568.pdf
Size
885.38 KB
Format
Adobe PDF
Checksum (MD5)
c0670c82eb8fb8a13ccbb846c550cc51
Author(s)
Al Abosy, Jude
Kalavacherla, Sruthi
Koutoujian, Peter J.
Siddiqi, Kashif
Senst, Thomas
Caro, Jose
Grossman, Anna
Dong, Kimberly R.
Date Issued
November 26, 2025
Journal
BMC Public Health
Publisher
BioMed Central
Citation
Al Abosy, J., Kalavacherla, S., Koutoujian, P.J. et al. PrEP attitudes, willingness, and preferences among men incarcerated in jail in Massachusetts. BMC Public Health 25, 4329 (2025).
Version
Final published version
Abstract
Background People who inject drugs (PWID) are both disproportionately incarcerated and affected by HIV infection. Systemic inequities perpetuate the cyclic nature of injection drug use (IDU) and incarceration, and both IDU and incarceration are linked to higher rates of HIV infection. Pre-exposure prophylaxis (PrEP) is highly effective in HIV prevention and is currently available as a daily oral pill. Longer-acting PrEP options, such as injectables and implants, are also in development to improve accessibility and adherence. Despite these advancements, PrEP uptake remains low among PWID and individuals recently released from jail, and there is limited literature exploring the preferences for PrEP uptake within this population. Methods We conducted qualitative interviews using a semi-structured interview guide with 20 male participants (19 incarcerated in a Massachusetts jail and 1 recently released) to assess perceived HIV risk, knowledge of PrEP, barriers to PrEP uptake, and preferences for PrEP modality and frequency. The data were analyzed using a directed content analysis approach. Results Most participants were aware of their HIV risk but were largely unaware of PrEP and had never been educated about PrEP by a healthcare provider. Participants cited a lack of access to healthcare, stigma around HIV infection, and feasibility as barriers to uptake. While participants expressed interest in longer-acting PrEP, most preferred the oral pill due to distrust of the safety and efficacy of injectables and implants, countering the assumption that modality changes alone can improve low PrEP uptake. Conclusions Our findings underscore the urgent need for targeted education and interventions to improve HIV prevention in vulnerable populations impacted by incarceration. While long-acting injectables have been touted to help address barriers to accessing healthcare among this population, skepticism about the efficacy of long-acting injectables among this population may prevent these efforts. It is important to further research the willingness to uptake PrEP and modality preferences among this population to meet their needs.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-NonCommercial-NoDerivatives
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1186/s12889-025-25568-x
